← Latest Filings
F
Flynn James E
Open-market buys
4
$25.0M total
Open-market sells
2
$70.9M total
Tracking since
Nov 2025
Activity timeline
Open-market buy — $10.0M
Larimar Therapeutics, Inc. · Feb 27, 2026
Open-market buy — $4.2M
Larimar Therapeutics, Inc. · Feb 27, 2026
Open-market trades from the last two years.
Holdings as last reported
10,622,957 Common Stock in LRMR
Held indirectly (Through Deerfield Private Design Fund IV, L.P.) · as of 2026-02-27
10,622,928 Common Stock in LRMR
Held indirectly (Through Deerfield Private Design Fund III, L.P.) · as of 2026-02-27
Companies touched
Larimar Therapeutics, Inc.
CIK 0001374690
Parabilis Medicines, Inc.
CIK 0001657677
